A research team from The Hong Kong University of Science and Technology, under the leadership of Prof. Hsing I-Ming, has made notable strides in CRISPR technology.
This new approach aims to enhance the precision of gene editing, potentially leading to advancements in diagnostics and antiviral therapies.
The collaboration includes experts from various institutions, highlighting the collective effort in pushing the boundaries of biotechnology.